Frédéric Massicotte

659 total citations
18 papers, 559 citations indexed

About

Frédéric Massicotte is a scholar working on Rheumatology, Molecular Biology and Pharmacology. According to data from OpenAlex, Frédéric Massicotte has authored 18 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 6 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Frédéric Massicotte's work include Rheumatoid Arthritis Research and Therapies (8 papers), Osteoarthritis Treatment and Mechanisms (7 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Frédéric Massicotte is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Osteoarthritis Treatment and Mechanisms (7 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Frédéric Massicotte collaborates with scholars based in Canada, Germany and United Kingdom. Frédéric Massicotte's co-authors include Daniel Lajeunesse, Johanne Martel‐Pelletier, Jean‐Pierre Pelletier, George Hilal, Julio Fernandes, Mohamed Benderdour, N. Duval, Johanne Martel‐Pelletier, G. Bleau and Jean‐Pierre Pelletier and has published in prestigious journals such as Journal of Bone and Mineral Research, Annals of the Rheumatic Diseases and Bone.

In The Last Decade

Frédéric Massicotte

15 papers receiving 540 citations

Peers

Frédéric Massicotte
Johanne Martel‐Pelletier Canada
B.C. Søndergaard Denmark
Sabrina Priam France
Kirsty L. Culley United States
Pradeep Kumar Sacitharan United Kingdom
Evelyne Dombrecht Belgium
Helal Endisha Canada
Jean-Pierre Pelletier Canada
Chihiro Nakatomi Japan
Hee Kyoung Kang South Korea
Johanne Martel‐Pelletier Canada
Frédéric Massicotte
Citations per year, relative to Frédéric Massicotte Frédéric Massicotte (= 1×) peers Johanne Martel‐Pelletier

Countries citing papers authored by Frédéric Massicotte

Since Specialization
Citations

This map shows the geographic impact of Frédéric Massicotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Massicotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Massicotte more than expected).

Fields of papers citing papers by Frédéric Massicotte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Massicotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Massicotte. The network helps show where Frédéric Massicotte may publish in the future.

Co-authorship network of co-authors of Frédéric Massicotte

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Massicotte. A scholar is included among the top collaborators of Frédéric Massicotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Massicotte. Frédéric Massicotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Choquette, D., Louis Bessette, Boulos Haraoui, et al.. (2020). AB0337 TOFACITINIB MONOTHERAPY OR COMBINED WITH METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS SHOW SIMILAR RETENTION OVER FOUR YEARS. REPORT FROM RHUMADATA ®. Annals of the Rheumatic Diseases. 79. 1467–1467. 2 indexed citations
3.
Choquette, D., Louis Bessette, Frédéric Massicotte, et al.. (2019). AB0740 USE OF SECUKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS. IMPACTS OF COMBINATION WITH METHOTREXATE. Annals of the Rheumatic Diseases. 78. 1835–1835. 3 indexed citations
4.
Choquette, D., Louis Bessette, Frédéric Massicotte, et al.. (2019). SAT0120 COMPARATIVE EFFECTIVENESS OF TOFACITINIB AND TNF INHIBITORS SINCE 2014. IMPACT OF COMBINATION WITH METHOTREXATE. Annals of the Rheumatic Diseases. 78. 1128–1128. 3 indexed citations
5.
Choquette, D., Louis Bessette, Frédéric Massicotte, et al.. (2019). FRI0084 THE IMPACT OF IL-6 AND TNF INHIBITORS ON HEMOGLOBIN LEVELS: AN ANALYSIS FROM RHUMADATA® CLINICAL DATABASE AND REGISTRY. Annals of the Rheumatic Diseases. 78. 705–705. 4 indexed citations
6.
Choquette, D., Louis Bessette, E. Alemao, et al.. (2017). FRI0230 Retention rates of tnf inhibitors and abatacept used as a first biologic dmard in the treatment of rheumatoid arthritis: 8 years of experience from the rhumadata® registry. Annals of the Rheumatic Diseases. 76. 571–572. 2 indexed citations
7.
Raynauld, J.-P., Louis Bessette, James A. Brown, et al.. (2016). THU0034 Use of Rituximab Compared To Anti-Tnf Agents as Second and Third-Line Therapy in Patients with Rheumatoid Arthritis. A 6-Year Follow-Up Report from The Rhumadata® Clinical Database and Registry. Annals of the Rheumatic Diseases. 75. 190–190. 1 indexed citations
8.
9.
Massicotte, Frédéric, Isabelle Aubry, Johanne Martel‐Pelletier, et al.. (2006). Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts. Arthritis Research & Therapy. 8(6). R177–R177. 47 indexed citations
10.
Massicotte, Frédéric, Julio Fernandes, Johanne Martel‐Pelletier, Jean‐Pierre Pelletier, & Daniel Lajeunesse. (2005). Modulation of insulin-like growth factor 1 levels in human osteoarthritic subchondral bone osteoblasts. Bone. 38(3). 333–341. 55 indexed citations
11.
Lajeunesse, Daniel, et al.. (2003). Subchondral bone sclerosis in osteoarthritis: not just an innocent bystander. Modern Rheumatology. 13(1). 7–14. 36 indexed citations
12.
Martel‐Pelletier, Johanne, Frédéric Massicotte, Ginette Tardif, et al.. (2003). Human Adult Chondrocytes Express Hepatocyte Growth Factor (HGF) Isoforms but Not HGF: Potential Implication of Osteoblasts on the Presence of HGF in Cartilage. Journal of Bone and Mineral Research. 18(6). 1073–1081. 51 indexed citations
13.
Lajeunesse, Daniel, Frédéric Massicotte, Jean‐Pierre Pelletier, & Johanne Martel‐Pelletier. (2003). Subchondral bone sclerosis in osteoarthritis: not just an innocent bystander. Modern Rheumatology. 13(1). 7–14. 10 indexed citations
14.
Reboul, Pascal, Johanne Martel‐Pelletier, Frédéric Massicotte, et al.. (2003). Hepatocyte growth factor in osteoarthritis: when bone and cartilage decide to have a chat. Arthritis Research. 5(Suppl 3). 162–162.
15.
Massicotte, Frédéric, Daniel Lajeunesse, Mohamed Benderdour, et al.. (2002). Can altered production of interleukin-1β, interleukin-6, transforming growth factor-β and prostaglandin E2 by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthritis and Cartilage. 10(6). 491–500. 153 indexed citations
16.
17.
Hilal, George, Frédéric Massicotte, Johanne Martel‐Pelletier, et al.. (2001). Endogenous Prostaglandin E2 and Insulin-like Growth Factor 1 Can Modulate the Levels of Parathyroid Hormone Receptor in Human Osteoarthritic Osteoblasts. Journal of Bone and Mineral Research. 16(4). 713–721. 60 indexed citations
18.
Bleau, G., et al.. (1999). Mammalian chitinase-like proteins. Birkhäuser Basel eBooks. 87. 211–221. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johanne Martel‐Pelletier Breakdown of academic impact, for papers by B.C. Søndergaard Breakdown of academic impact, for papers by Sabrina Priam Breakdown of academic impact, for papers by Kirsty L. Culley Breakdown of academic impact, for papers by Pradeep Kumar Sacitharan Breakdown of academic impact, for papers by Evelyne Dombrecht Breakdown of academic impact, for papers by Helal Endisha Breakdown of academic impact, for papers by Jean-Pierre Pelletier Breakdown of academic impact, for papers by Chihiro Nakatomi Breakdown of academic impact, for papers by Hee Kyoung Kang
Rankless by CCL
2026